Manager/Sr. Manager, IR & Corporate Communications

San Diego, CA (Unknown)

$145K/yr – $215K/yrSenior Level5+ years exp

Posted 1 day ago

Job Summary

Own and drive Kura’s corporate communications and investor relations program, leading content, calendar, events, and cross-functional reviews while shaping messaging for corporate, investor, and employee audiences.

  • Lead day-to-day communications activities including content development, channel management, and editorial calendars.
  • Coordinate investor relations materials, executive visibility, digital and employee communications with cross-functional partners.

Job Description

Responsibilities

  • The Mgr/Sr. Manager, Corporate Communications and Investor Relations will play a critical role in advancing Kura’s integrated communications and investor relations strategy through clear, compelling messaging and effective execution. Working closely with the SVP, Investor Relations and Corporate Affairs, and the Senior Director, Corporate Communications, this individual will own day-to-day communications activities, including content development, channel management, editorial calendars, event planning, and cross-functional review processes.
  • Corporate communications: Contribute to communications strategy and lead execution of assigned initiatives that advance Kura’s corporate narrative, visibility, and reputation.
  • Content and messaging: Develop clear, audience-specific communications that translate complex scientific and business information into compelling content, maintaining consistent messaging across corporate, investor, and employee communications.
  • Product and milestone communications: Partner with clinical, commercial, and other cross-functional teams to plan and execute communications supporting key data, development, and commercial milestones.
  • Investor relations: Draft and help refine earnings and other corporate announcements, investor presentations, conference call scripts, and supporting materials. Manage updates to the corporate pipeline slide and corresponding digital content. Coordinate cross functional input and reviews to ensure accuracy, consistency and timely publication. Coordinate preparation and logistics for investor conferences and events and maintain investor contact databases.
  • Market and stakeholder insights: Monitor peer communications, industry developments, and investor themes; synthesize relevant findings and recommend implications for Kura’s messaging and communications priorities.
  • Digital communications: Manage corporate social media and website content, including editorial planning, publishing, and performance measurement. Coordinate with Commercial and other partners to align content and obtain appropriate reviews. Monitor social media channels for relevant activity, competitive posts, and emerging conversations.
  • Employee communications: Partner with Human Resources and company leaders to develop communications that help employees understand company priorities, connect with Kura’s mission, and stay informed about progress and milestones. Draft articles for the Company intranet and lead distribution of internal newsletter.
  • Executive visibility: Coordinate leadership participation in media interviews, speaking engagements, and other external opportunities. Prepare supporting briefing materials, talking points and presentations.
  • Patient and community engagement: Collaborate with internal partners to support communications for patient advocacy, community relations, and corporate giving initiatives.

Requirements

  • Accredited Bachelor’s degree preferably in Communications, English, Journalism or related field
  • 5+ years of experience in integrated corporate communications or a related field; biopharmaceutical industry experience in a corporate or agency role strongly preferred
  • Outstanding interpersonal and communication skills, both written and verbal, including ability to demonstrate strong presence and cultivate relationships with senior leadership team
  • Self starter with excellent organizational skills and attention to detail, with the ability to manage multiple concurrent workstreams, track and meet deadlines, and proactively identify and resolve issues
  • Hands-on experience executing corporate social media programs, including content drafting, graphic design, calendar management, Reg FD principles and cross-functional content coordination
  • Experience working with agency partners
  • Track record of managing issues and ability to stay calm under pressure in a fast-paced environment
  • Strong working knowledge of essential computer applications (i.e. MS Word, Excel, PowerPoint, CRM)
  • Fluency with IR analytics platforms (e.g., Nasdaq IR Insight, FactSet/Irwin, AlphaSense, etc)

Benefits

  • Career advancement/ development opportunities
  • Generous Benefits Package with a variety of plans available with a substantial employer match
  • Paid Paternity/Maternity Leave
  • In-Office Catered lunches
  • Home Office Setup
  • Lifestyle Spending Stipend
  • Commuter Stipend (Boston Office)
  • Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!
Kura Oncology logo

Kura Oncology

3.4 Glassdoor

Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura’s pipeline consists of three investigational drug candidates: ziftomenib, tipifarnib and KO-2806. Ziftomenib is a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction for the treatment of genetically defined AML patients with high unmet need. Ziftomenib is currently enrolling patients in a Phase 2 registration-directed trial (KOMET-001) in NPM1-mutant relapsed or refractory AML. Kura is preparing to initiate multiple Phase 1 trials to evaluate ziftomenib in combination with current standards of care in earlier lines of therapy and across multiple patient populations, including NPM1-mutant and KMT2A-rearranged AML. Tipifarnib, a potent and selective FTI, is currently in a Phase 1/2 trial (KURRENT-HN) in combination with alpelisib for patients with PIK3CA-dependent HNSCC. Kura intends to evaluate KO-2806, a next-generation FTI, in a Phase 1 dose-escalation trial (FIT-001) as a monotherapy and in combination with other targeted therapies in adult patients with advanced solid tumors. For additional information, please visit Kura’s website at www.kuraoncology.com.

Founded in 2014
San Diego, California, USA
309 employees (21 in marketing)
60% recommend to a friend

Salaries

Posted range

$145K/yr – $215K/yr

Taken straight from the job posting.

See all Kura Oncology salaries

Marketing Team

Marketing Team Size
21 (7% of company)
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$1.2B
Last Raise
$150M
Post IPO Equity, 2 years ago

Funding History

  • Jan 2024
    Post IPO Equity • $150M
  • Jun 2023
    Post IPO Equity • $100M
  • Nov 2022
    Post IPO Equity • $25M

Traffic Signals

Monthly Visitors
15.7K
Monthly Google Ads Budget
$40
Traffic Source Mix
Search
45.8%
Direct
39.4%
Referral
6.9%
Social
6.4%
Paid
1.3%

Headcount Trend

Current headcount: ~311

Recent News

Kura Oncology logo

Manager/Sr. Manager, IR & Corporate Communications

Kura Oncology · San Diego, CA · Unknown